Evidence map›Paper›PMID 39123421›Full record

ArticleCancers2024

Augmenting CT-Guided Bone Biopsies Using

Max F Droste, Floris H P van Velden, Matthias N van Oosterom, Valentijn J Luijk, Mark C Burgmans, Tessa Buckle, Fijs W B van Leeuwen, Daphne D D Rietbergen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Max F DrosteSection of Nuclear Medicine, Department of Radiology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Floris H P van VeldenSection of Nuclear Medicine, Department of Radiology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.ORCID 0000-0003-2859-2119
Matthias N van OosteromInterventional Molecular Imaging Laboratory, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Valentijn J LuijkInterventional Molecular Imaging Laboratory, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Mark C BurgmansSection of Interventional Radiology, Department of Radiology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.ORCID 0000-0001-5258-291X
Tessa BuckleInterventional Molecular Imaging Laboratory, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Fijs W B van LeeuwenInterventional Molecular Imaging Laboratory, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Daphne D D RietbergenSection of Nuclear Medicine, Department of Radiology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.ORCID 0000-0001-9873-6179

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Computer tomography (CT)-guided percutaneous core biopsies are currently the gold standard in diagnostic procedures for patients with bone lesions of unknown kind. CT-guided biopsies can lead to misdiagnosis or repetition of biopsies in case of small or heterogeneous lesions. We hypothesize that molecular image guidance could be used to optimize the biopsy strategy, by supporting the detection of heterogeneous lesions or lesions without radiographic substrate. To evaluate this hypothesis, we investigated if and how the addition of 2-deoxy-2-

Indexed as

18F-FDG PET/CTbone lesionsCT-guided biopsyhistopathologyimage-guided bone biopsy

Identifiers

PMID39123421
PMCPMC11311694

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.